EBM Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


First published online June 5, 2008
Experimental Biology and Medicine doi: 10.3181/0802-RM-35
© 2008 by the Society for Experimental Biology and Medicine

This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
233/9/1161    most recent
0802-RM-35v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Google Scholar
Right arrow Articles by Pujal, J.-M.
Right arrow Articles by Gallardo, D.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Pujal, J.-M.
Right arrow Articles by Gallardo, D.


Regular Manuscript

PCR-based methodology for molecular microchimerism detection and quantification

Josep-Maria Pujal 1* and David Gallardo 1

1 Hospital Duran i Reynals - Institut Catala d'Oncologia

* To whom correspondence should be addressed. E-mail: jmpujal{at}idibell.org.


   Abstract

Background: Peripheral blood microchimerism after pregnancy or solid organ transplantation has been widely studied but a consensus on its detection has not yet been adopted. Objectives: To establish a panel of reproducible molecular PCR-based methods for detection and quantification of foreign cells in an individual. Methods: We analysed length polymorphisms generated by STR and VNTR markers. HLA-A and -B polymorphisms were detected by RSCA. Class II polymorphisms on HLA-DRB1 locus were analysed both by classical PCR-SSP and by quantitative PCR (Q-PCR). Also, SRY gene allowed specific male donor discrimination and quantification by Q-PCR in female recipients. Binomial statistical distribution analysis was used for each molecular technique to determine the number of PCR replicates of each sample. This analysis allowed the detection of lowest detectable microchimerism level, when present. Results: We could detect microchimerism in more than 96% and more than 86% of cases at levels as low as 1:10e5 and 1:10e6 donor per recipient cells (DPRC) respectively, using Q-PCR for SRY or for non-shared HLA-DRB1 alleles. These techniques allowed as low as 1 genome-equivalent cell detection. Lower levels (nanochimerism) could be detected but not quantified due to technique limitations. On the other hand, classical PCR methods allowed detection down to 1:10e4 DPRC for HLA-DRB1 SSP-PCR. The clinical application of these techniques in solid organ transplanted recipients showed microchimerism levels ranging from 1:10e4 to 1:10e6 DPRC after kidney or heart transplantation, and 1 log higher (1:10e3 to 1:10e6 DPRC) after liver transplantation. Conclusion: The standardization of molecular microchimerism detection techniques will allow for comparable interpretation of results in microchimerism detection for diagnostic or research studies.

Key Words: Microchimerism, Transplantation, Macrochimerism, Quantification







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2008 by the Society for Experimental Biology and Medicine.